We are live on ! Find out more
IOVA icon

Iovance Biotherapeutics

246 hedge funds and large institutions have $2.96B invested in Iovance Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 95 increasing their positions, 85 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $76.2M | Put options by funds: $17.6M

18% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 34

12% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 85

1% more funds holding

Funds holding: 243246 (+3)

2.55% less ownership

Funds ownership: 101.91%99.36% (-2.5%)

24% less capital invested

Capital invested by funds: $3.88B → $2.96B (-$921M)

57% less funds holding in top 10

Funds holding in top 10: 73 (-4)

Holders
246
Holders Change
+3
Holders Change %
+1.23%
% of All Funds
3.79%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.05%
New
40
Increased
95
Reduced
85
Closed
34
Calls
$76.2M
Puts
$17.6M
Net Calls
+$58.6M
Net Calls Change
+$39M
Name Holding Trade Value Shares
Change
Change in
Stake
SWA
276
Sutton Wealth Advisors
Florida
-$1.13K -46 Closed
FWA
277
FSC Wealth Advisors
New York
+$220 +10 New
Carson Wealth (CWM LLC)
278
Carson Wealth (CWM LLC)
Nebraska
+$264 +12 New
CSWM
279
Cassady Schiller Wealth Management
Ohio
+$286 +13 New
LWA
280
Lenox Wealth Advisors
New York
+$528 +24 New